SCHEMBL7130573

SCHEMBL7130573

COC(=O)c1cccc(NC(=O)c2cc([N+](=O)[O-])ccc2Cl)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.71
KMT2A Q03164 8/20 0.71
RORC P51449 5/20 0.68
SMN1; SMN2 Q16637 5/20 0.68
MAPT P10636 5/20 0.68
MAPK1 P28482 4/20 0.68
CYP3A4 P08684 3/20 0.68
PPARG P37231 2/20 0.68
CYP1A2 P05177 2/20 0.68
CYP2C19 P33261 2/20 0.68
PKM P14618 2/20 0.68
LMNA P02545 1/20 0.68
TP53 P04637 1/20 0.68
CYP2D6 P10635 1/20 0.68
CYP2C9 P11712 1/20 0.68
TSHR P16473 1/20 0.68
NFKB1 P19838 1/20 0.68
THPO P40225 1/20 0.68
MTOR P42345 1/20 0.68
PMP22 Q01453 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7119934 0.90 RORC (0.73) MEN1KMT2ARORCSMN1; SMN2MAPT
SCHEMBL7122886 0.87 RORC (0.77) MEN1KMT2ARORCSMN1; SMN2MAPT
SCHEMBL7130551 0.85 RORC (0.82) MEN1KMT2ARORCSMN1; SMN2MAPT
SCHEMBL13709151 0.85 MEN1 (0.72) MEN1KMT2ASMN1; SMN2MAPTMAPK1
SCHEMBL7127748 0.83 SMN1; SMN2 (0.74) MEN1KMT2ARORCSMN1; SMN2MAPT
SCHEMBL16494872 0.83 MEN1 (0.81) MEN1KMT2ASMN1; SMN2MAPTMAPK1
SCHEMBL18147368 0.83 RORC (0.78) MEN1KMT2ARORCSMN1; SMN2MAPT
SCHEMBL7128796 0.83 PPARG (0.70) MEN1KMT2ARORCSMN1; SMN2MAPT
SCHEMBL7120440 0.82 SMN1; SMN2 (0.81) MEN1KMT2ARORCSMN1; SMN2MAPT
SCHEMBL29369092 0.81 RORC (1.00) MEN1KMT2ARORCSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD MEN1 4865/4885KMT2A 3291/4885RORC 67/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.